Overview: Two Leading Approaches to Vein Closure
Endovenous laser ablation (EVLA) has been a gold standard for varicose vein treatment for over two decades. VenaBlock®, a non-thermal cyanoacrylate closure system, offers a compelling alternative. This article compares both methods across the metrics that matter most to physicians and patients.
Mechanism of Action
EVLA uses laser energy (typically 1470 nm wavelength) delivered through a fiber inside the vein, generating heat that damages the vein wall and causes fibrotic closure. The procedure requires tumescent anesthesia — multiple perivenous injections along the entire vein length — to protect surrounding tissues from thermal injury.
VenaBlock® uses medical-grade cyanoacrylate adhesive delivered through a catheter, sealing the vein mechanically without generating any heat. Only a single needle puncture and one local anesthetic injection at the access site are required.
Efficacy Comparison
A 2021 two-year follow-up study comparing VenaBlock® with 1470 nm laser ablation found comparable long-term disease progression outcomes (44.2% vs. 34.8%), despite VenaBlock® showing higher recanalization rates at the 2-year mark (37.2% vs. 8.7%). However, more recent data with optimized technique shows significantly improved closure rates for VenaBlock®, with 6-month rates of 97.5% and 12-month rates of 93.75% in registry studies.
Safety Profile
| Outcome | VenaBlock® | EVLA |
|---|---|---|
| Risk of nerve damage | Negligible | Low–moderate |
| Skin burns | None | Possible |
| Post-procedure bruising | Minimal | Common |
| Phlebitis/inflammation | Low | Moderate |
Patient Comfort
EVLA requires up to 50–80 ml of tumescent anesthesia injected along the vein — a process many patients find uncomfortable. VenaBlock® requires only one injection. Post-procedure pain scores are consistently lower with cyanoacrylate closure in comparative studies.
Recovery Time
Both procedures are outpatient. With VenaBlock®, most patients walk out within 30 minutes and return to normal activities the same day. EVLA patients typically need 24–48 hours of restricted activity and mandatory compression stocking use for 1–2 weeks.
Conclusion
For patients prioritizing minimal discomfort, faster recovery, and no thermal risk, VenaBlock® is a strong choice. EVLA remains highly effective, particularly for very large-diameter veins. The ideal choice depends on individual patient anatomy, preferences, and physician experience.